| E8M Stock | | | EUR 0.02 0 10.00% |
CTO
Gabriel Ettenson is Global Chief Technology Officer of Elixinol Wellness Limited since 2019.
| Tenure | 5 years |
| Phone | 61 2 4044 4585 |
| Web | https://www.elixinolwellness.com |
Elixinol Wellness Management Efficiency
The company has return on total asset
(ROA) of
(0.3266) % which means that it has lost $0.3266 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.7075) %, meaning that it generated substantial loss on money invested by shareholders. Elixinol Wellness' management efficiency ratios could be used to measure how well Elixinol Wellness manages its routine affairs as well as how well it operates its assets and liabilities.
Elixinol Wellness Limited has accumulated 250
K in total debt with debt to equity ratio
(D/E) of 0.07, which may suggest the company is not taking enough advantage from borrowing. Elixinol Wellness has a current ratio of 6.94, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Elixinol Wellness until it has trouble settling it off, either with new capital or with free cash flow. So, Elixinol Wellness' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Elixinol Wellness sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Elixinol to invest in growth at high rates of return. When we think about Elixinol Wellness' use of debt, we should always consider it together with cash and equity.
Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. The company was incorporated in 2017 and is headquartered in Sydney, Australia. ELIXINOL GLOBAL operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. Elixinol Wellness Limited (E8M) is traded on Frankfurt Exchange in Germany and employs 16 people.
Management Performance
Elixinol Wellness Leadership Team
Elected by the shareholders, the Elixinol Wellness' board of directors comprises two types of representatives: Elixinol Wellness inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elixinol. The board's role is to monitor Elixinol Wellness' management team and ensure that shareholders' interests are well served. Elixinol Wellness' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elixinol Wellness' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Greg Smith, Global Chief Information Officer | |
| Kim BradleyWare, Joint Sec | |
| Oliver Horn, Chief Executive Officer, Director | |
| Glen Zurcher, Account Department | |
| Paul Benhaim, Non-Executive Chairman of the Board | |
| Leif Harrison, Chief Executive Officer of America | |
| Teresa Cleary, Global General Counsel, Company Secretary | |
| Rob Hasselman, Pres Americas | |
| Gabriel Ettenson, Global Chief Technology Officer | |
| Helen Wiseman, Non-Executive Chairman of the Board | |
| FCPA BEC, Interim Officer | |
| Ali Atcha, Chief Executive Officer of Europe & UK | |
| Josephine Lorenz, Global Controller | |
| Linda McLeod, Managing Director | |
| Ron Dufficy, Global Chief Financial Officer | |
| Beata Silber, Global Innovation | |
Elixinol Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Elixinol Wellness a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Elixinol Stock
Elixinol Wellness financial ratios help investors to determine whether Elixinol Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elixinol with respect to the benefits of owning Elixinol Wellness security.